Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 2022 AR2
The report highlights Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.'s performance in 2022, achieving an operating income of RMB 70.79 billion, up 2.57% year-on-year. The company advanced its 'Great Southern TCM', 'Great Health', 'Great Commerce', and 'Great Medical Care' segments, including the completion of the Guangyao Wanglaoji Guangdong Lychee Industrial Park. In scientific innovation, the company's Ganoderma lucidum project won a gold medal at the Geneva International Exhibition of Inventions, and its subsidiary obtained FDA approval for BYS10 tablet clinical trials. Additionally, the company completed the acquisition of an additional 18.18% equity interest in GP Corp., increasing its shareholding to 90.92%.
Company: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Sector: Health Care
Country: China
Year: 2022
Type: AR2
Pages: 391
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Annual Report
The report highlights Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.'s performance in 2022, achieving an operating income of RMB 70.79 billion, up 2.57% year-on-year. The company advanced its 'Great Southern TCM', 'Great Health', 'Great Commerce', and 'Great Medical Care' segments, including the completion of the Guangyao Wanglaoji Guangdong Lychee Industrial Park. In scientific innovation, the company's Ganoderma lucidum project won a gold medal at the Geneva International Exhibition of Inventions, and its subsidiary obtained FDA approval for BYS10 tablet clinical trials. Additionally, the company completed the acquisition of an additional 18.18% equity interest in GP Corp., increasing its shareholding to 90.92%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees